世界の網膜静脈閉塞症（RVO）治療市場は2023年に約26億5,000万米ドルと評価され、2024年から2032年の予測期間にわたって6.92%の年間複合成長率（CAGR）を示すことが予測されています。
網膜静脈閉塞症は視力喪失の大きな原因であり、重篤な合併症を防ぐためにタイムリーで効果的な治療戦略が必要です。治療法には、抗VEGF注射、コルチコステロイド、レーザー療法などがあり、網膜の腫れを軽減し、この病気でよく見られる血管の異常増殖を防ぐことを目的としています。これらの治療は、視力を維持し、黄斑浮腫や血管新生緑内障などの網膜静脈閉塞症関連の合併症の進行を防ぐのに不可欠です。
世界の人口の高齢化は、RVO治療市場の主な推進力です。人口の高齢化に伴い、網膜血管の自然な変性によりRVOの発生率が増加し、効果的な治療ソリューションが必要になります。さらに、治療技術、特にラニビズマブやアフリベルセプトなどの抗VEGF薬の開発における継続的な進歩が、市場の成長を後押ししています。これらの進歩により治療結果が大幅に向上し、世界中の何百万人もの患者に希望を与えています。さらに、目の健康に対する意識の高まりと早期診断の重要性が市場を牽引しており、より多くの人々がRVOを効果的に管理および治療するためにタイムリーな介入を求めています。また、新興市場は、特にRVOの主なリスク要因である糖尿病と高血圧の有病率の上昇により、大きな成長の機会をもたらします。これらの地域では医療インフラが改善し続けているため、高度なRVO治療の需要が高まることが予想されます。さらに、生物学的製剤や個別化医療の開発により、よりカスタマイズされた効果的な治療が可能になるため、市場がさらに拡大することが期待されます。ただし、市場は課題に直面しており、特に生物学的製剤によるRVO治療のコストが高いことが顕著です。これらの治療は高額な場合が多く、低所得地域の患者には利用できません。保険適用範囲の不十分さと償還の課題により、費用負担の問題はさらに深刻化しており、患者がこれらの必須治療を受ける機会が制限される可能性があります。
2023年には、北アメリカが世界のRVO治療市場を支配し、その高度な医療インフラと眼関連の問題の蔓延率の高さにより大きなシェアを占めました。この地域のよく規制された医療システムと主要な業界プレーヤーの存在も、市場の成長に貢献しています。一方、アジア太平洋地域は、日本、中国、インドなどの国での新しい治療法の採用の増加と医療インフラへの多額の投資により、予測期間中に最も急速な成長が見込まれています。
目次
Table of Contents
Chapter 1. Global Retinal Vein Occlusion Treatment Market Executive Summary
1.1. Global Retinal Vein Occlusion Treatment Market Size & Forecast (2022- 2032)
1.2. Regional Summary
1.3. Segmental Summary
1.3.1. By Disease Type
1.3.2. By Treatment
1.3.3. By End-user
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion
Chapter 2. Global Retinal Vein Occlusion Treatment Market Definition and Research Assumptions
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
2.3.1. Inclusion & Exclusion
2.3.2. Limitations
2.3.3. Supply Side Analysis
2.3.3.1. Availability
2.3.3.2. Infrastructure
2.3.3.3. Regulatory Environment
2.3.3.4. Market Competition
2.3.3.5. Economic Viability (Consumer's Perspective)
2.3.4. Demand Side Analysis
2.3.4.1. Regulatory frameworks
2.3.4.2. Technological Advancements
2.3.4.3. Environmental Considerations
2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates
Chapter 3. Global Retinal Vein Occlusion Treatment Market Dynamics
3.1. Market Drivers
3.1.1. Aging Population
3.1.2. Advancements in Therapeutic Technologies
3.1.3. Rising Awareness and Early Diagnosis
3.2. Market Challenges
3.2.1. High Treatment Costs
3.3. Market Opportunities
3.3.1. Emerging Markets
3.3.2. Biologics and Personalized Medicine
Chapter 4. Global Retinal Vein Occlusion Treatment Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model
4.1.7. Porter's 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top investment opportunity
4.4. Top winning strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Global Retinal Vein Occlusion Treatment Market Size & Forecasts by Disease Type 2022-2032
5.1. Segment Dashboard
5.2. Global Retinal Vein Occlusion Treatment Market: Disease Type Revenue Trend Analysis, 2022 & 2032 (USD Billion)
5.2.1. Central Retinal Vein Occlusion (CRVO)
5.2.2. Branch Retinal Vein Occlusion (BRVO)
Chapter 6. Global Retinal Vein Occlusion Treatment Market Size & Forecasts by Treatment 2022-2032
6.1. Segment Dashboard
6.2. Global Retinal Vein Occlusion Treatment Market: Treatment Revenue Trend Analysis, 2022 & 2032 (USD Billion)
6.2.1. Anti-vascular Endothelial Growth Factor (Anti-VEGF)
6.2.2. Corticosteroid Drugs
6.2.3. Others
Chapter 7. Global Retinal Vein Occlusion Treatment Market Size & Forecasts by End-user 2022-2032
7.1. Segment Dashboard
7.2. Global Retinal Vein Occlusion Treatment Market: End-user Revenue Trend Analysis, 2022 & 2032 (USD Billion)
7.2.1. Hospital & Clinics
7.2.2. Retail Pharmacy
7.2.3. Others
Chapter 8. Global Retinal Vein Occlusion Treatment Market Size & Forecasts by Region 2022-2032
8.1. North America Retinal Vein Occlusion Treatment Market
8.1.1. U.S. Retinal Vein Occlusion Treatment Market
8.1.1.1. Disease Type breakdown size & forecasts, 2022-2032
8.1.1.2. Treatment breakdown size & forecasts, 2022-2032
8.1.1.3. End-user breakdown size & forecasts, 2022-2032
8.1.2. Canada Retinal Vein Occlusion Treatment Market
8.2. Europe Retinal Vein Occlusion Treatment Market
8.2.1. U.K. Retinal Vein Occlusion Treatment Market
8.2.2. Germany Retinal Vein Occlusion Treatment Market
8.2.3. France Retinal Vein Occlusion Treatment Market
8.2.4. Spain Retinal Vein Occlusion Treatment Market
8.2.5. Italy Retinal Vein Occlusion Treatment Market
8.2.6. Rest of Europe Retinal Vein Occlusion Treatment Market
8.3. Asia-Pacific Retinal Vein Occlusion Treatment Market
8.3.1. China Retinal Vein Occlusion Treatment Market
8.3.2. India Retinal Vein Occlusion Treatment Market
8.3.3. Japan Retinal Vein Occlusion Treatment Market
8.3.4. Australia Retinal Vein Occlusion Treatment Market
8.3.5. South Korea Retinal Vein Occlusion Treatment Market
8.3.6. Rest of Asia Pacific Retinal Vein Occlusion Treatment Market
8.4. Latin America Retinal Vein Occlusion Treatment Market
8.4.1. Brazil Retinal Vein Occlusion Treatment Market
8.4.2. Mexico Retinal Vein Occlusion Treatment Market
8.4.3. Rest of Latin America Retinal Vein Occlusion Treatment Market
8.5. Middle East & Africa Retinal Vein Occlusion Treatment Market
8.5.1. Saudi Arabia Retinal Vein Occlusion Treatment Market
8.5.2. South Africa Retinal Vein Occlusion Treatment Market
8.5.3. Rest of Middle East & Africa Retinal Vein Occlusion Treatment Market
Chapter 9. Competitive Intelligence
9.1. Key Company SWOT Analysis
9.2. Top Market Strategies
9.3. Company Profiles
9.3.1. AbbVie Inc.
9.3.1.1. Key Information
9.3.1.2. Overview
9.3.1.3. Financial (Subject to Data Availability)
9.3.1.4. Product Summary
9.3.1.5. Market Strategies
9.3.2. F. Hoffmann-La Roche Ltd.
9.3.3. Regeneron Pharmaceuticals Inc.
9.3.4. Aerie Pharmaceuticals Inc.
9.3.5. Pfizer Inc.
9.3.6. Taiwan Liposome Company, Ltd.
9.3.7. CalciMedica Inc.
9.3.8. Kodiak Sciences Inc.
9.3.9. Chugai Pharmaceutical Co., Ltd.
9.3.10. Outlook Therapeutics, Inc.
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
List of Tables
TABLE 1. Global Retinal Vein Occlusion Treatment market, report scope
TABLE 2. Global Retinal Vein Occlusion Treatment market estimates & forecasts by Region 2022-2032 (USD Billion)
TABLE 3. Global Retinal Vein Occlusion Treatment market estimates & forecasts by Disease Type 2022-2032 (USD Billion)
TABLE 4. Global Retinal Vein Occlusion Treatment market estimates & forecasts by Treatment 2022-2032 (USD Billion)
TABLE 5. Global Retinal Vein Occlusion Treatment market by segment, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 6. Global Retinal Vein Occlusion Treatment market by region, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 7. Global Retinal Vein Occlusion Treatment market by segment, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 8. Global Retinal Vein Occlusion Treatment market by region, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 9. Global Retinal Vein Occlusion Treatment market by segment, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 10. Global Retinal Vein Occlusion Treatment market by region, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 11. Global Retinal Vein Occlusion Treatment market by segment, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 12. Global Retinal Vein Occlusion Treatment market by region, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 13. Global Retinal Vein Occlusion Treatment market by segment, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 14. Global Retinal Vein Occlusion Treatment market by region, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 15. U.S. Retinal Vein Occlusion Treatment market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 16. U.S. Retinal Vein Occlusion Treatment market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 17. U.S. Retinal Vein Occlusion Treatment market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 18. Canada Retinal Vein Occlusion Treatment market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 19. Canada Retinal Vein Occlusion Treatment market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 20. Canada Retinal Vein Occlusion Treatment market estimates & forecasts by segment 2022-2032 (USD Billion)
This list is not complete, final report does contain more than 100 tables. The list may be updated in the final deliverable.
List of Figures
FIG 1. Global Retinal Vein Occlusion Treatment market, research methodology
FIG 2. Global Retinal Vein Occlusion Treatment market, market estimation techniques
FIG 3. Global market size estimates & forecast methods.
FIG 4. Global Retinal Vein Occlusion Treatment market, key trends 2023
FIG 5. Global Retinal Vein Occlusion Treatment market, growth prospects 2022-2032
FIG 6. Global Retinal Vein Occlusion Treatment market, porters 5 force model
FIG 7. Global Retinal Vein Occlusion Treatment market, PESTEL analysis
FIG 8. Global Retinal Vein Occlusion Treatment market, value chain analysis
FIG 9. Global Retinal Vein Occlusion Treatment market by segment, 2022 & 2032 (USD Billion)
FIG 10. Global Retinal Vein Occlusion Treatment market by segment, 2022 & 2032 (USD Billion)
FIG 11. Global Retinal Vein Occlusion Treatment market by segment, 2022 & 2032 (USD Billion)
FIG 12. Global Retinal Vein Occlusion Treatment market by segment, 2022 & 2032 (USD Billion)
FIG 13. Global Retinal Vein Occlusion Treatment market by segment, 2022 & 2032 (USD Billion)
FIG 14. Global Retinal Vein Occlusion Treatment market, regional snapshot 2022 & 2032
FIG 15. North America Retinal Vein Occlusion Treatment market 2022 & 2032 (USD Billion)
FIG 16. Europe Retinal Vein Occlusion Treatment market 2022 & 2032 (USD Billion)
FIG 17. Asia Pacific Retinal Vein Occlusion Treatment market 2022 & 2032 (USD Billion)
FIG 18. Latin America Retinal Vein Occlusion Treatment market 2022 & 2032 (USD Billion)
FIG 19. Middle East & Africa Retinal Vein Occlusion Treatment market 2022 & 2032 (USD Billion)
FIG 20. Global Retinal Vein Occlusion Treatment market, company market share analysis (2023)
This list is not complete, final report does contain more than 50 figures. The list may be updated in the final deliverable.
